Routy et al. (2018) reported that fecal material from NSCLC patients who responded well to anti-PD-1 treatment when transplanted to germ-free mice resulted in delayed tumor growth, as compared to the mice fed with fecal material from patients who did not respond to the anti-PD-1 therapy [13] (Figure 3). Here, PDCD1 is linked to neoplasm.